PPAR : a dagger in the heart of the metabolic syndrome
Open accessThe DOI matches its Crossref record; 97 of the 100 references it cites were found in a registry or an index.
Abstract
Obesity is a growing threat to global health by virtue of its association with insulin resistance, glucose intolerance, hypertension, and dyslipidemia, collectively known as the metabolic syndrome or syndrome X. The nuclear receptors PPARalpha and PPARgamma are therapeutic targets for hypertriglyceridemia and insulin resistance, respectively, and drugs that modulate these receptors are currently in clinical use. More recent work on the less-described PPAR isotype PPARdelta has uncovered a dual benefit for both hypertriglyceridemia and insulin resistance, highlighting the broad potential of PPARdelta in the treatment of metabolic disease. PPARdelta enhances fatty acid catabolism and energy uncoupling in adipose tissue and muscle, and it suppresses macrophage-derived inflammation. Its combined activities in these and other tissues make it a multifaceted therapeutic target for the metabolic syndrome with the potential to control weight gain, enhance physical endurance, improve insulin sensitivity, and ameliorate atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both overexpression and activation of PPARδ result in increased mitochondrial biogenesis in the absence of an increase in PGC-1α mRNA in skeletal muscle in vivo (17–19).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [19]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The finding that overexpression of PPARδ in skeletal muscle of transgenic mice does not result in an increase in PGC-1α mRNA led to the conclusion that the increase in mitochondria is mediated directly by PPARδ (17–19).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [19]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In contrast to the finding in mouse and rat skeletal muscle that PPARδ overexpression or activation does not result in an increase in PGC-1α mRNA, a number of studies have shown that PPARδ induces an increase in PGC-1α gene transcription, with a rapid increase in PGC-1α mRNA, in myotubes (19, 50, 51).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [19]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The regulation of PGC-1α expression by PPARδ differs markedly between skeletal muscle in vivo and myotubes in culture.”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Research works printed but not linked: 1
- [77]Lee, C.H., et al. 2006. PPAR delta is a potent insulin sensitizer. Proc. Natl. Acad. Sci. U. S. A. In press.
Cited by
Items 501–600 of 738
Identification of PPAR-activating compounds in herbal and edible plants and fungi from Vietnam
Ngoc, L. P., Man, H.-Y., Besselink, H., Cam, H. D. T., Brouwer, A., & van der Burg, B. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2018.12.003 · Cited by 7
Liu, H.-X., & Liu, Q.-J. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2063430 · Cited by 7
Merz, M. P., Seal, S. V., Grova, N., Mériaux, S. B., Guébels, P., Kanli, G., Mommaerts, E., Nicot, N., Kaoma, T., Keunen, O., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-56601-5 · Cited by 7
PPARs: Important Regulators in Metabolism and Inflammation
Sanderson, L. M., & Kersten, S. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_10 · Cited by 7
Nuclear Receptors and Female Reproduction: A Tale of 3 Scientists, Jensen, Gustafsson, and O’Malley
Chaudhuri, G. (2008) · Reproductive Sciences · doi:10.1177/1933719108314516 · Cited by 7
Balakumar, P., Rose, M., & Singh, M. (2007) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2007.205.219 · Cited by 7
Myers, R. B., & Yoshioka, J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00169.2015 · Cited by 7
Andrews, D. B., Schwimmer, J. B., & Lavine, J. E. (2008) · Hepatology · doi:10.1002/hep.22505 · Cited by 7
Äikäs, L., Kovanen, P. T., Lorey, M. B., Laaksonen, R., Holopainen, M., Ruhanen, H., Käkelä, R., Jauhiainen, M., Hermansson, M., & Öörni, K. (2025) · JCI Insight · doi:10.1172/jci.insight.193637 · Cited by 6
Structure optimization of a new class of PPARγ antagonists
Hernández‐Olmos, V., Knape, T., Heering, J., von Knethen, A., Kilu, W., Kaiser, A., Wurglics, M., Helmstädter, M., Merk, D., Schubert‐Zsilavecz, M., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115082 · Cited by 6
Turza, A., Păşcuţă, P., Mureșan-Pop, M., Mare, L., Borodi, G., & Popescu, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050623 · Cited by 6
“PPAR-δ receptor activation plays a role in metabolism and promotes the burning of fatty acids via the mechanism of up-regulation of fatty acid uptake and oxidation [4,5].”
BackgroundPPARδas a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
Glazer, R. I. (2016) · PPAR Research · doi:10.1155/2016/3082340 · Cited by 6
Chauhan, A. K., Grewal, A. S., Pandita, D., & Lather, V. (2019) · Current Drug Discovery Technologies · doi:10.2174/1570163816666190314124543 · Cited by 6
Nishida, Y., Iyadomi, M., Tominaga, H., Taniguchi, H., Higaki, Y., Tanaka, H., Horita, M., Shimanoe, C., Hara, M., & Tanaka, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030703 · Cited by 6
“While PPAR-α and PPAR-γ are preferentially expressed in liver and adipose tissue, respectively [1], PPAR-δ is ubiquitously expressed throughout the body, and its expression is especially high in skeletal muscle compared with the other two isoforms [3,4].”
BackgroundReyna, S., Valenzuela, R., & Villanueva, M. E. (2018) · Revista chilena de nutrición · doi:10.4067/s0717-75182018000300153 · Cited by 6
Kim, M., Kim, C., & Hwang, J. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4485 · Cited by 6
“24,26 SOE treatment increased the activation of PGC-1 a and PPAR d in the skeletal muscles of ND and HFD mice, which was mediated by AMPK and SIRT1, resulting in enhanced mitochondrial biogenesis, increased muscle fiber type switching, and upregulation of the AMPK/SIRT1/ PGC-1 a /PPAR d signaling…”
Telmisartan Protects Auditory Hair Cells from Gentamicin-Induced Toxicity in vitro
Cortada, M., Wei, E., Jain, N., Levano, S., & Bodmer, D. (2020) · Audiology and Neurotology · doi:10.1159/000506796 · Cited by 6
Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2008) · Lifestyle Genomics · doi:10.1159/000112460 · Cited by 6
Current and novel therapies for the treatment of nonalcoholic steatohepatitis
van der Poorten, D., & George, J. (2007) · Hepatology International · doi:10.1007/s12072-007-9011-8 · Cited by 6
Improvement of myocardial lipid accumulation and prevention of PGC-1α induction by fenofibrate
Zang, M. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.841 · Cited by 6
Venkata, N. G., Aung, C. S., Cabot, P. J., Monteith, G. R., & Roberts‐Thomson, S. J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm281 · Cited by 6
Hyperlipidemia and cardiovascular disease
Kuller, L. H. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32805dfb47 · Cited by 6
Insulin Resistance and Cardiovascular Disease
Wang, C. C. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_12 · Cited by 5
Wegner, C., Kim, B., & Lee, J. (2013) · Nutrients · doi:10.3390/nu5010208 · Cited by 5
Saha, P. S., Sawtelle, K. R. K., Bamberg, B. N., Arrick, D. M., Watt, M. J., Scholl, J. L., Zheng, H., & Mayhan, W. G. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14634 · Cited by 5
PPARδ activation or overexpression attenuates PGC-1α protein degradation
고진호, Ahn, N., Kim, K., & Hong-soo, K. (2015) · Exercise Science · doi:10.15857/ksep.2015.24.1.49 · Cited by 5
Kato, T., Ohara, T., Suzuki, N., Naya, N., Fukao, K., Tokuyama, R., Muto, S., Fukasawa, H., Itai, A., & Matsumura, K. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117215 · Cited by 5
Amaral, A. U., Cecatto, C., da Silva, J. C., Wajner, A., & Wajner, M. (2017) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409817701472 · Cited by 5
Gu, H., Li, J., Fei, Y., Zuo, B., & Xu, Z. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04805-8 · Cited by 5
Prevention of Cardiovascular Complications of the Metabolic Syndrome: Focus on Pharmacotherapy
Krentz, A. J. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.328 · Cited by 5
Shi, Y., Jiang, H., & Yang, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6483 · Cited by 5
Oh, J., Chung, J.-H., & Kang, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071013 · Cited by 5
Yu, X., Zhang, Y., Wu, B., Zhao, B., & Wang, C. (2025) · Drug Metabolism Reviews · doi:10.1080/03602532.2025.2558654 · Cited by 4
ROLE OF PPAR-* IN DETERMINATION OF MUSCLE FIBER TYPE IN RESPONSE TO EXERCISE
Vitošević, B., Ranković, G. Ž., & Popović-Ilić, T. (2011) · Acta Medica Medianae · doi:10.5633/amm.2011.0211 · Cited by 4
Development of Synthetic Modulators of PPARs: Current Challenges and Future Opportunities
Pinaire, J. A., Miller, A. R., & Gregoire, F. M. (2008) · PPAR Research · doi:10.1155/2008/786359 · Cited by 4
The relationship of lipid imbalance and chronic inflammation mediated by PPAR
Čavojský, T., Bilka, F., & Paulíková, I. (2016) · Česká a slovenská farmacie · doi:10.36290/csf.2016.001 · Cited by 4
Prabakaran, A. D., Karakkat, J. V., Vijayan, R., Chalissery, J., Ibrahim, M. F., Kaimala, S., Adeghate, E. A., Al-Marzouqi, A. H., Ansari, S. A., Mensah‐Brown, E. P. K., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031815 · Cited by 4
“…γ acts by binding to Ppar-responsive regulatory element (PPRE) as an obligate heterodimer with retinoid X receptors (Rxr proteins) and controls different cellular processes, including regulation of lipid and carbohydrate metabolism (Evans et al., 2004; Barish et al., 2006; Ahmadian et al., 2013).”
Kato, T., Ohara, T., Suzuki, N., Muto, S., Tokuyama, R., Mizutani, M., Fukasawa, H., Matsumura, K., & Itai, A. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128567 · Cited by 4
Nutrigenomics: Insights and Implications for Genome-Based Nutrition
Rajesh, S., Varanavasiappan, S., & Ramesh, S. V. (2022) · Springer eBooks · doi:10.1007/978-981-19-4590-8_10 · Cited by 4
Chapter 1 Regulation of Metabolism by Nuclear Hormone Receptors
Huang, H.-J., & Schulman, I. G. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87001-4 · Cited by 4
Quang, T. H., Ngân, N. T. T., Minh, C. V., Kiệm, P. V., Nhiệm, N. X., Tài, B. H., Thảo, N. P., Luyen, B. T. T., Song, S., & Kim, Y. H. (2011) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2011.32.11.4049 · Cited by 4
Matilainen, M. (2007) · UEF eRepo (University of Eastern Finland) · Cited by 4
Mahmoud, A. M., & Dera, H. S. A. (2016) · Genes & Nutrition · doi:10.1186/s12263-016-0548-9 · Cited by 4
Huu, T. N., Thanh, H. D., Kim, M.-K., Sah, D. K., Trinh, V. H., Yoon, H. J., Choi, J. M., Lee, G.-H., Kim, S., & Lee, S.-R. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00094-x · Cited by 3
Rubio, B., Pintado, C., Mazuecos, L., Benito, M., Andrés, A., & Gallardo, N. (2024) · Biomolecules · doi:10.3390/biom14081028 · Cited by 3
“Given that PPAR β / δ has been implicated in the regulation of ion channels and cellular processes involved in cardiac repolarization [23–25], antagonism of PPAR β / δ may disrupt these processes, leading to QT prolongation.”
BackgroundGoto, T., Takahashi, N., & Kawada, T. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.s128 · Cited by 3
Exploring PPAR Modulation in Experimental Mice
Rull, A., Aragonès, G., Beltrán‐Debón, R., Rodríguez‐Gallego, E., Camps, J., & Joven, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-155-4_19 · Cited by 3
Peroxisome Proliferator-Activated Receptor-Review
Adedapo, A. D. A., Asunloye, O. O., & Adeoye, B. O. (2018) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2018/40221 · Cited by 3
Wang, F., Lei, L., Wang, Z., Yin, Y., Yang, H., Yang, Z., & Chen, J. (2022) · Czech Journal of Animal Science · doi:10.17221/103/2022-cjas · Cited by 3
Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets
Rapuano, R., Mercuri, A., Dallavalle, S., Moricca, S., Lavecchia, A., & Lupo, A. (2024) · Biomolecules · doi:10.3390/biom14080998 · Cited by 3
Development of compounds for targeted degradation of mammalian cryptochrome proteins.
Munns, J., Beale, A. D., Michaelides, I. N., Peak‐Chew, S., Mihut, A., Styles, C. T., Zeng, A., Storer, R. I., Edgar, R. S., Moreau, K., et al. (2025) · PubMed Central · doi:10.1098/rstb.2023.0342 · Cited by 3
“…of the latter, deletion of CRY1 and CRY2 reportedly resulted in abnormal expression of target genes: PPARδ [32], which regulates lipid metabolism [33] and the glucocorticoid receptor [4], the pleiotropic regulator of glucose homeostasis, immunosuppression and other diverse cellular processes…”
Muscle-Specific PPAR β/δ Agonism May Provide Synergistic Benefits with Life Style Modifications
Erol, A. (2007) · PPAR Research · doi:10.1155/2007/30578 · Cited by 3
“Additionally, PPARs may suppress inflammation through the stabilization of repressive complexes at inflammatory gene promoters [3].”
BackgroundInfluentialEndogenous ligand for an orphan receptor
Wolf, G. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00289.x · Cited by 3
Stefanski, A., & Majkowska, L. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.12.1713 · Cited by 3
“Also, influence of PPARδ on macrophage cholesterol homeostasis and its involvement in atherogenic inflammation may have implications for the development of atherosclerosis [32].”
BackgroundPaliwal, S., Yadav, D., Yadav, R., Kaushik, V., & Paliwal, S. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9599-z · Cited by 3
“in these and other tissues make it a multifaceted therapeutic target for the metabolic syndrome with the potential to control weight gain, enhance physical endurance, improve insulin sensitivity, and ameliorate atherosclerosis (Barish et al., 2006).”
BackgroundPeroxisome Proliferator-Activated Nuclear Receptors and Drug Addiction
Mascia, P., Tanda, G., Yaşar, S., Heishman, S. J., & Goldberg, S. R. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_11 · Cited by 3
Chang, P., Chen, L., & Cheng, J. (2014) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2013.05.001 · Cited by 3
Linkage and Association Analyses of Longitudinally Measured Lipid Phenotypes in Adolescence
Middelberg, R. P. S., Gordon, S. D., Zhu, G., McRae, A. F., Montgomery, G. W., Martin, N. G., & Whitfield, J. B. (2008) · Twin Research and Human Genetics · doi:10.1375/twin.11.6.603 · Cited by 3
“1, is a member of the PPARD subfamily of nuclear receptors, and acts as a sensor for polyunsaturated fatty acids and VLDL lipoprotein particles (Barish et al., 2006).”
BackgroundLo, S., Lee, K., Chen, L., Cheng, J., & Chen, C. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.04.013 · Cited by 3
“PPARδ-dependent maintenance of inotropic function and metabolic effects is crucial for cardiomyocytes (Cheng et al., 2004a, 2004b; Barish et al., 2006).”
Bairy, P. S. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i12.21596 · Cited by 3
Antitumor activity of a PPARδ antagonist
Elikkottil, J., Kohli, D. R., & Gupta, K. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.13.9061 · Cited by 3
Viñas, R. (2007) · ThinkTech (Texas Tech University) · Cited by 3
Kuchta, K., Matsuura, N., Tùng, N. H., Rusch, C., Iinuma, M., Shoyama, Y., & Rauwald, H. W. (2025) · Molecules · doi:10.3390/molecules30020419 · Cited by 2
Choi, H., An, S., Hyun, Y. E., Noh, M., & Jeong, L. S. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108042 · Cited by 2
Glazer, R. I., & Kopelovich, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17302 · Cited by 2
The Dual Transcriptional Activity of Retinoic Acid
Noy, N. (2015) · Wiley eBooks · doi:10.1002/9781118628003.ch11 · Cited by 2
Chapter 12 Recent Trends in HDL Modulating Therapies
De, D., & Khanna, I. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42012-7 · Cited by 2
Peroxisome Proliferator Activated Receptor-δ (PPAR-δ)
Choi, K. M. (2007) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2007.31.4.297 · Cited by 2
Aspectos actuales y perspectiva de futuro del tratamiento del s?ndrome metab?lico
Arponen, S. M., & Fern�ndez, C. (2006) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(06)74449-6 · Cited by 2
Nutritional Genomics: Cellular Signaling and Molecular Targets
Bidlack, W. R. (2011) · CRC Press eBooks · doi:10.1201/b11294-8 · Cited by 2
Air Pollution and Endocrine-Disrupting Chemicals
Annamalai, J., & Vasudevan, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-62731-1_21 · Cited by 2
Therapeutic Potential of PPARs in Alzheimer’s Disease
Upaganlawar, A. B., Upasani, C. D., & Ihim, S. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_14 · Cited by 2
The role of PPARs in inflammation and obesity
Stienstra, R. (2007) · doi:10.18174/121898 · Cited by 2
Fernández‐Fernández, F. J. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3956 · Cited by 2
Estudo do controle traducional de PPAR durante o processo de diferenciação de macrófagos
Cambiaghi, T. D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2010.tde-25032010-145009 · Cited by 2
“Também acredita-se que possui função importante na proliferação e diferenciação celulares [Barish et al., 2006; Escher et al., 2001; Wang et al., 2003].”
BackgroundResponses to environmental xenobiotics: from endocrine disruption to lipid homeostasis imbalance
Dimastrogiovanni, G. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 2
Davidson, M. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22317 · Cited by 2
Peroxisome Proliferator-Activated Receptors
Pinaire, J. A., & Reifel-Miller, A. E. (2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_228 · Cited by 2
PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expressionPreprint
Yang, Q., Liang, Y., Inoue-Hatanaka, T., Koh, Z., Ilkenhans, N., Suman, E., Yu, J., & Zheng, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628819 · Cited by 2
Li, J., Sun, R., Zhao, T., Tang, X., Gao, B., Xu, G., Wang, Y., Yu, H., Meng, Q., & Zhang, Z. (2026) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2026.101748 · Cited by 1
Mitochondrial control of amino acid catabolism by a fasting-inducible mitochondrial carrier
Oikawa, S., Yamamuro, T., Nishida, H., Katoh, D., Wang, D., Fujimoto, M., & Kajimura, S. (2026) · Science Advances · doi:10.1126/sciadv.aef0140 · Cited by 1
AMPK: Central Regulator of Glucose and Lipid Metabolism
Mihaylova, M. M., & Shaw, R. J. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch35 · Cited by 1
Jain, M. K. (2008) · Nature Medicine · doi:10.1038/nm0608-603 · Cited by 1
Fat Feeding and Muscle Fat Deposition Eliciting Insulin Resistance
Kraegen, E. W., Cooney, G. J., Ye, J. M., & Furler, S. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_16 · Cited by 1
Rhodiola Rosea: From the Adaptogenic Role to the Anti-Adipogenic Effect?
Colitti, M. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000e123 · Cited by 1
Reciprocal Crosstalk Between Angiogenesis and Metabolism
Laurent, G., & Mechta‐Grigoriou, F. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0466-8_10 · Cited by 1
Potential Health Benefits of Rice By-products
Tan, B. L., & Norhaizan, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-46153-9_5 · Cited by 1
Wondimnew, T., Genet, S., & Gnanasekaran, N. (2021) · Free Radicals and Antioxidants · doi:10.5530/fra.2020.2.14 · Cited by 1
Behari, J. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_29 · Cited by 1
Al-Naemi, A. H. (2022) · Annals of the College of Medicine Mosul/Annals of the College of Medecine · doi:10.33899/mmed.2022.133951.1148 · Cited by 1
Relevant Pharmacology and Interventions
Watson, A., & Hand, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-72862-4_3 · Cited by 1
The regulation of metabolic gene expression in humans
Tisdale, P. B. (2011) · Nottingham ePrints (University of Nottingham) · Cited by 1
Exploring the activation and function of PPARa and PPARß/d using genomics
Sanderson-Kjellberg, L. M. (2009) · doi:10.18174/11781 · Cited by 1
Synthesis of putative peroxisome proliferator-activated receptor δ antagonists
Vo, C. X. T. (2012) · NORA - Norwegian Open Research Archives · Cited by 1
Angiopoietin-like protein 4 : an unfolding chaperone regulating lipoprotein lipase activity
Sukonina, V. (2007) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Abscisic acid ameliorates glucose tolerance and obesity-induced inflammation
Guri, A. J. (2007) · VTechWorks (Virginia Tech) · Cited by 1
Takahama, C. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2016.tde-26092016-125014 · Cited by 1
The role of the clock in lipid metabolism
Ahern, S. A. (2017) · Research Explorer (The University of Manchester) · Cited by 1
Metadata
- Authors
- Barish, G. D.
- Affiliations
- Salk Institute for Biological Studies (US)
- Corresponding author
- Barish, G. D.
- ORCID
- Barish, G. D.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-03-01
- Volume
- 116
- Issue
- 3
- Pages
- 590-597
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1386117
- OpenAlex
- W1987601141
- Cited by
- 641
- References
- 100
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 16 · 2023: 7 · 2022: 12 · 2021: 9 · 2020: 23 · 2019: 15 · 2018: 24 · 2017: 26 · 2016: 28 · 2015: 29 · 2014: 31 · 2013: 39 · 2012: 46
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- March of Dimes Foundation
- Larry L. Hillblom Foundation
- National Institutes of Health (U19DK62434)
- University of California, San Diego
- National Heart, Lung, and Blood Institute (P50HL56989, P50HL056989)
- National Institute of Diabetes and Digestive and Kidney Diseases (U19 DK-62434, U19DK062434, F32DK071478)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- PPARδ, PPARα, PPARγ, metabolic syndrome, insulin resistance, hypertriglyceridemia, obesity, fatty acid degradation, adipose tissue, skeletal muscle, macrophage inflammation, atherosclerosis, nuclear receptors, weight gain, physical endurance
- MeSH terms
- Animals, Humans, Myocardium, Muscle, Skeletal, Metabolic Syndrome, PPAR delta, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.